株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

経腔的末梢血管形成 (PTA) 向け薬剤溶出バルーン (DEB):パイプライン分析

Peripheral Transluminal Angioplasty Drug Eluting Balloons (DEB) - Pipeline Review, 2015

発行 GlobalData 商品コード 338380
出版日 ページ情報 英文 80 Pages
即納可能
価格
本日の銀行送金レート: 1USD=115.27円で換算しております。

2016年12月31日まで 年末キャンペーン割引: GlobalData社発行レポート
ご注意: ショッピングカートでは適用されませんので、割引価格についてはお問い合わせください

Back to Top
経腔的末梢血管形成 (PTA) 向け薬剤溶出バルーン (DEB):パイプライン分析 Peripheral Transluminal Angioplasty Drug Eluting Balloons (DEB) - Pipeline Review, 2015
出版日: 2015年07月28日 ページ情報: 英文 80 Pages
概要

当レポートでは、世界各国の企業・医療機関などで開発中の、PTA (経腔的末梢血管形成) 薬剤溶出バルーン (DEB) のパイプライン製品情報について分析し、治験/製品開発の全体的な進行状況や、段階別・分野別・地域別の詳細動向、企業別・製品別の詳細情報 (治験の進行段階、開始/終了時期、認証見通しなど)、昨今の製品開発の動き・業界動向などを盛り込んでお届けいたします。

第1章 目次

第2章 イントロダクション

  • PTA (経腔的末梢血管形成) 薬剤溶出バルーン (DEB)の概要

第3章 開発中の製品

  • パイプライン製品:開発段階別
  • パイプライン製品:部門別
  • パイプライン製品:地域別
  • パイプライン製品:規制経路別
  • パイプライン製品:認証時期別 (推定)
  • 現在進行中の治験

第4章 PTA薬剤溶出バルーン (DEB):開発中のパイプライン製品 (企業別)

  • PTA薬剤溶出バルーンの開発企業:パイプライン製品 (開発段階別)
  • PTA薬剤溶出バルーン:開発段階別のパイプライン製品の一覧

第5章 PTA薬剤溶出バルーン (DEB) の開発企業・製品の概要

  • AnGes MG, Inc.
    • パイプライン製品および進行中の治験の概要
  • AngioCure, Inc. Company Overview
  • AVIDAL Vascular GmbH
  • Bayer HealthCare AG
  • C. R. Bard, Inc.
  • Contego Medical, LLC
  • eucatech AG
  • Eurocor GmbH
  • Genesis Technologies, Inc (Inactive)
  • Lifetech Scientific (Shenzhen) Co., Ltd.
  • Micell Technologies, Inc.
  • Minvasys
  • Neovasc Inc.
  • ニプロ
  • QT Vascular Ltd.
  • Rontis AG
  • SiL Vascular Ltd
  • SurModics, Inc.
  • テルモ
  • The Spectranetics Corporation
  • Vascular Nanotransfer Technologies

第6章 PTA薬剤溶出バルーン (DEB):昨今の市場動向

第7章 付録

図表一覧

目次
Product Code: GDME0054EPD

GlobalData's Medical Devices sector report, "Peripheral Transluminal Angioplasty Drug Eluting Balloons (DEB) - Pipeline Review, 2015" provides an overview of Peripheral Transluminal Angioplasty (PTA) Drug Eluting Balloons (DEB) currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Peripheral Transluminal Angioplasty Drug Eluting Balloons (DEB) pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

  • Extensive coverage of the Peripheral Transluminal Angioplasty Drug Eluting Balloons (DEB) under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Peripheral Transluminal Angioplasty Drug Eluting Balloons (DEB) and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry

Reasons to buy

The report enables you to -

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Peripheral Transluminal Angioplasty Drug Eluting Balloons (DEB) under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product's current stage of development, territory and estimated launch date

Table of Contents

1. Table of Contents

  • 1.1. List of Tables
  • 1.2. List of Figures

2. Introduction

  • 2.1. Peripheral Transluminal Angioplasty Drug Eluting Balloons (DEB) Overview

3. Products under Development

  • 3.1. PTA Peripheral Drug Eluting Balloons (DEB) - Pipeline Products by Stage of Development
  • 3.2. PTA Peripheral Drug Eluting Balloons (DEB) - Pipeline Products by Territory
  • 3.3. PTA Peripheral Drug Eluting Balloons (DEB) - Pipeline Products by Regulatory Path
  • 3.4. PTA Peripheral Drug Eluting Balloons (DEB) - Pipeline Products by Estimated Approval Date
  • 3.5. PTA Peripheral Drug Eluting Balloons (DEB) - Ongoing Clinical Trials

4. PTA Peripheral Drug Eluting Balloons (DEB) - Pipeline Products under Development by Companies

  • 4.1. PTA Peripheral Drug Eluting Balloons (DEB) Companies - Pipeline Products by Stage of Development
  • 4.2. PTA Peripheral Drug Eluting Balloons (DEB) - Pipeline Products by Stage of Development

5. PTA Peripheral Drug Eluting Balloons (DEB) Companies and Product Overview

  • 5.1. AnGes MG, Inc. Company Overview
    • 5.1.1. AnGes MG, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.2. AngioCure, Inc. Company Overview
    • 5.2.1. AngioCure, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.3. AVIDAL Vascular GmbH Company Overview
    • 5.3.1. AVIDAL Vascular GmbH Pipeline Products & Ongoing Clinical Trials Overview
  • 5.4. Bayer HealthCare AG Company Overview
    • 5.4.1. Bayer HealthCare AG Pipeline Products & Ongoing Clinical Trials Overview
  • 5.5. C. R. Bard, Inc. Company Overview
    • 5.5.1. C. R. Bard, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.6. Contego Medical, LLC Company Overview
    • 5.6.1. Contego Medical, LLC Pipeline Products & Ongoing Clinical Trials Overview
  • 5.7. eucatech AG Company Overview
    • 5.7.1. eucatech AG Pipeline Products & Ongoing Clinical Trials Overview
  • 5.8. Eurocor GmbH Company Overview
    • 5.8.1. Eurocor GmbH Pipeline Products & Ongoing Clinical Trials Overview
  • 5.9. Genesis Technologies, Inc (Inactive) Company Overview
    • 5.9.1. Genesis Technologies, Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
  • 5.10. Lifetech Scientific (Shenzhen) Co., Ltd. Company Overview
    • 5.10.1. Lifetech Scientific (Shenzhen) Co., Ltd. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.11. Micell Technologies, Inc. Company Overview
    • 5.11.1. Micell Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.12. Minvasys Company Overview
    • 5.12.1. Minvasys Pipeline Products & Ongoing Clinical Trials Overview
  • 5.13. Neovasc Inc. Company Overview
    • 5.13.1. Neovasc Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.14. Nipro Corporation Company Overview
    • 5.14.1. Nipro Corporation Pipeline Products & Ongoing Clinical Trials Overview
  • 5.15. QT Vascular Ltd. Company Overview
    • 5.15.1. QT Vascular Ltd. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.16. Rontis AG Company Overview
    • 5.16.1. Rontis AG Pipeline Products & Ongoing Clinical Trials Overview
  • 5.17. SiL Vascular Ltd Company Overview
    • 5.17.1. SiL Vascular Ltd Pipeline Products & Ongoing Clinical Trials Overview
  • 5.18. SurModics, Inc. Company Overview
    • 5.18.1. SurModics, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.19. Terumo Corporation Company Overview
    • 5.19.1. Terumo Corporation Pipeline Products & Ongoing Clinical Trials Overview
  • 5.20. The Spectranetics Corporation Company Overview
    • 5.20.1. The Spectranetics Corporation Pipeline Products & Ongoing Clinical Trials Overview
  • 5.21. Vascular Nanotransfer Technologies Company Overview
    • 5.21.1. Vascular Nanotransfer Technologies Pipeline Products & Ongoing Clinical Trials Overview

6. PTA Peripheral Drug Eluting Balloons (DEB)- Recent Developments

7. Appendix

  • 7.1. Methodology
  • 7.2. About GlobalData
  • 7.3. Contact Us
  • 7.4. Disclaimer

List of Tables

  • Table 1: PTA Peripheral Drug Eluting Balloons (DEB) - Pipeline Products by Stage of Development
  • Table 2: PTA Peripheral Drug Eluting Balloons (DEB) - Pipeline Products by Territory
  • Table 3: PTA Peripheral Drug Eluting Balloons (DEB) - Pipeline Products by Regulatory Path
  • Table 4: PTA Peripheral Drug Eluting Balloons (DEB) - Pipeline Products by Estimated Approval Date
  • Table 5: PTA Peripheral Drug Eluting Balloons (DEB) - Ongoing Clinical Trials
  • Table 6: PTA Peripheral Drug Eluting Balloons (DEB) Companies - Pipeline Products by Stage of Development
  • Table 7: PTA Peripheral Drug Eluting Balloons (DEB) - Pipeline Products by Stage of Development
  • Table 8: AnGes MG, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 9: Collategene Drug-Eluting Balloon Catheter - Product Status
  • Table 10: Collategene Drug-Eluting Balloon Catheter - Product Description
  • Table 11: NF-kB Decoy Oligo Coated PTA Balloon Catheter - Product Status
  • Table 12: NF-kB Decoy Oligo Coated PTA Balloon Catheter - Product Description
  • Table 13: AngioCure, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 14: AngioCure TOP-C Smart Balloon Catheter - Product Status
  • Table 15: AngioCure TOP-C Smart Balloon Catheter - Product Description
  • Table 16: AVIDAL Vascular GmbH Pipeline Products & Ongoing Clinical Trials Overview
  • Table 17: WOMBAT - Peripheral Version - Product Status
  • Table 18: WOMBAT - Peripheral Version - Product Description
  • Table 19: Bayer HealthCare AG Pipeline Products & Ongoing Clinical Trials Overview
  • Table 20: Cotavance Paclitaxel Coated Balloon Angioplasty Catheter - Product Status
  • Table 21: Cotavance Paclitaxel Coated Balloon Angioplasty Catheter - Product Description
  • Table 22: Bayer HealthCare AG - Ongoing Clinical Trials Overview
  • Table 23: Cotavance Paclitaxel Coated Balloon Angioplasty Catheter - Cotavance Paclitaxel-Coated Balloon Versus Uncoated Balloon Angioplasty for Treatment of In-stent Restenosis in SFA and Popliteal Arteries COPA CABANA Study
  • Table 24: Cotavance Paclitaxel Coated Balloon Angioplasty Catheter - European study of POBA versus Cotavance - Paclitaxel Coated Balloon for Infrapopliteal Lesions in Critical Limb Ischemia
  • Table 25: Cotavance Paclitaxel Coated Balloon Angioplasty Catheter - IDE Study of POBA versus Cotavance-Paclitaxel Coated Balloon for Infrapopliteal Lesions in Critical Limb Ischemia
  • Table 26: C. R. Bard, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 27: Lutonix 014 DCB Catheter - Product Status
  • Table 28: Lutonix 014 DCB Catheter - Product Description
  • Table 29: C. R. Bard, Inc. - Ongoing Clinical Trials Overview
  • Table 30: Lutonix 014 DCB Catheter - A Prospective, Global Multicenter, Single Arm Real-World Registry Investigating the Clinical Use and Safety of the LUTONIX Drug Coated PTA Dilatation Catheter
  • Table 31: Lutonix 014 DCB Catheter - A Prospective, Multi-center, Registry of the Lutonix Drug Coated Balloon for Treatment of Femoropopliteal Arteries (LEVANT 2 Safety Registry)
  • Table 32: Lutonix 014 DCB Catheter - A Prospective, Multi-center, Single Blind, Randomized, Controlled Japanese Population Trial Comparing MD02-LDCB Versus Standard Balloon Angioplasty For Treatment Of Femoropopliteal Arteries
  • Table 33: Lutonix 014 DCB Catheter - A Prospective, Multicenter, Single Blind, Randomized, Controlled Trial Comparing the Lutonix Drug Coated Balloon Versus Standard Balloon Angioplasty for Treatment of Below-the-Knee (BTK) Arteries (Lutonix BTK Trial)
  • Table 34: Contego Medical, LLC Pipeline Products & Ongoing Clinical Trials Overview
  • Table 35: Tibial Artery Drug Eluting Balloon - Product Status
  • Table 36: Tibial Artery Drug Eluting Balloon - Product Description
  • Table 37: eucatech AG Pipeline Products & Ongoing Clinical Trials Overview
  • Table 38: Support - Product Status
  • Table 39: Support - Product Description
  • Table 40: Eurocor GmbH Pipeline Products & Ongoing Clinical Trials Overview
  • Table 41: FREEWAY 014 Peripheral Drug Eluting Balloon - Product Status
  • Table 42: FREEWAY 014 Peripheral Drug Eluting Balloon - Product Description
  • Table 43: FREEWAY 035 Peripheral Drug-Eluting Balloon - Product Status
  • Table 44: FREEWAY 035 Peripheral Drug-Eluting Balloon - Product Description
  • Table 45: Eurocor GmbH - Ongoing Clinical Trials Overview
  • Table 46: FREEWAY 014 Peripheral Drug Eluting Balloon - Drug Eluting Balloon in Peripheral Intervention for Below-the-knee Arteries with Freeway and Lutonix
  • Table 47: FREEWAY 035 Peripheral Drug-Eluting Balloon - Drug Eluting Balloon in Peripheral Intervention for Below-the-knee Arteries with Freeway and Lutonix
  • Table 48: Genesis Technologies, Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
  • Table 49: Genesis DESA Balloon - Product Status
  • Table 50: Genesis DESA Balloon - Product Description
  • Table 51: Lifetech Scientific (Shenzhen) Co., Ltd. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 52: PTA Drug Eluting Balloon - Product Status
  • Table 53: PTA Drug Eluting Balloon - Product Description
  • Table 54: Micell Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 55: Drug-Coated Balloon - Product Status
  • Table 56: Drug-Coated Balloon - Product Description
  • Table 57: Minvasys Pipeline Products & Ongoing Clinical Trials Overview
  • Table 58: Danubio PTA Paclitaxel Eluting Over The Wire Balloon Catheter - Product Status
  • Table 59: Danubio PTA Paclitaxel Eluting Over The Wire Balloon Catheter - Product Description
  • Table 60: Danubio PTA Paclitaxel Eluting Rapid eXchange Balloon Catheter - Product Status
  • Table 61: Danubio PTA Paclitaxel Eluting Rapid eXchange Balloon Catheter - Product Description
  • Table 62: Neovasc Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 63: PTA Balloon Catheter - Product Status
  • Table 64: PTA Balloon Catheter - Product Description
  • Table 65: Nipro Corporation Pipeline Products & Ongoing Clinical Trials Overview
  • Table 66: Peripheral Drug-Eluting Balloon - Product Status
  • Table 67: Peripheral Drug-Eluting Balloon - Product Description
  • Table 68: QT Vascular Ltd. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 69: Chocolate Touch PTA Drug Coated Balloon - Product Status
  • Table 70: Chocolate Touch PTA Drug Coated Balloon - Product Description
  • Table 71: Silk PTA Balloon Catheter - Product Status
  • Table 72: Silk PTA Balloon Catheter - Product Description
  • Table 73: QT Vascular Ltd. - Ongoing Clinical Trials Overview
  • Table 74: Chocolate Touch PTA Drug Coated Balloon - Clinical Study Evaluating the Chocolate Touch PTCA Coronary Drug-coated Balloon
  • Table 75: Rontis AG Pipeline Products & Ongoing Clinical Trials Overview
  • Table 76: Drug Eluting Dilatation Catheter - Product Status
  • Table 77: Drug Eluting Dilatation Catheter - Product Description
  • Table 78: SiL Vascular Ltd Pipeline Products & Ongoing Clinical Trials Overview
  • Table 79: Peripheral Vascular Balloon - Product Status
  • Table 80: Peripheral Vascular Balloon - Product Description
  • Table 81: SurModics, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 82: SurVeil Drug Coated Balloon - Arterio Venous (AV) Fistulas - Product Status
  • Table 83: SurVeil Drug Coated Balloon - Arterio Venous (AV) Fistulas - Product Description
  • Table 84: SurVeil Drug Coated Balloon - Below The Knee (BTK) - Product Status
  • Table 85: SurVeil Drug Coated Balloon - Below The Knee (BTK) - Product Description
  • Table 86: Terumo Corporation Pipeline Products & Ongoing Clinical Trials Overview
  • Table 87: Drug Coated Balloon Catheter - Product Status
  • Table 88: Drug Coated Balloon Catheter - Product Description
  • Table 89: The Spectranetics Corporation Pipeline Products & Ongoing Clinical Trials Overview
  • Table 90: Stellarex Drug Coated Balloon - Below The Knee (BTK) - Product Status
  • Table 91: Stellarex Drug Coated Balloon - Below The Knee (BTK) - Product Description
  • Table 92: Stellarex Drug Coated Balloon - Superficial Femoral Artery - Product Status
  • Table 93: Stellarex Drug Coated Balloon - Superficial Femoral Artery - Product Description
  • Table 94: The Spectranetics Corporation - Ongoing Clinical Trials Overview
  • Table 95: Stellarex Drug Coated Balloon - Superficial Femoral Artery - Global Study Of A Drug-coated Balloon to Treat Obstructive SFA And/Or Popliteal Lesions
  • Table 96: Stellarex Drug Coated Balloon - Superficial Femoral Artery - ILLUMENATE First-in-Human (FIH) Study on the Safety and Effectiveness of Covidien's Advanced Drug-coated Balloon (DCB) Technology
  • Table 97: Stellarex Drug Coated Balloon - Superficial Femoral Artery - Prospective, Single-arm, Multi-center, Pharmacokinetic Study to Evaluate Treatment of Obstructive Superficial Femoral Artery or Popliteal Lesions with a Novel Paclitaxel-coated Percutaneous Angioplasty Balloon
  • Table 98: Vascular Nanotransfer Technologies Pipeline Products & Ongoing Clinical Trials Overview
  • Table 99: Mitomycin-Based Drug Coated Balloon - Peripheral - Product Status
  • Table 100: Mitomycin-Based Drug Coated Balloon - Peripheral - Product Description
  • Table 101: Paclitaxel-Based Drug Coated Balloon - Peripheral - Product Status
  • Table 102: Paclitaxel-Based Drug Coated Balloon - Peripheral - Product Description
  • Table 103: Glossary

List of Figures

  • Figure 1: PTA Peripheral Drug Eluting Balloons (DEB) - Pipeline Products by Stage of Development
  • Figure 2: PTA Peripheral Drug Eluting Balloons (DEB) - Pipeline Products by Territory
  • Figure 3: PTA Peripheral Drug Eluting Balloons (DEB) - Pipeline Products by Regulatory Path
  • Figure 4: PTA Peripheral Drug Eluting Balloons (DEB) - Pipeline Products by Estimated Approval Date
  • Figure 5: PTA Peripheral Drug Eluting Balloons (DEB) - Ongoing Clinical Trials
Back to Top